HR

Inflation Reduction Act's Impact on Healthcare and Equity
Management & Regulatory Inflation Reduction Act's Impact on Healthcare and Equity

The Inflation Reduction Act (IRA) marks a significant milestone in U.S. healthcare reform, particularly for those covered by Medicare. This comprehensive legislation introduces an array of policy changes poised to transform numerous sectors within the healthcare industry. One of the most crucial

April 29, 2024
Biopharma Industry Faces Wave of Layoffs Amidst Restructuring
Management & Regulatory Biopharma Industry Faces Wave of Layoffs Amidst Restructuring

The biopharmaceutical industry is currently navigating through turbulent waters as a series of layoffs and strategic overhauls ripple across the sector. The urgency that once underscored the COVID-19 pandemic has given way to a new reality where pharmaceutical giants are reassessing their

April 29, 2024
Ireland's Biopharma Sector: 21,000 Jobs Risk Skills Shortage
Management & Regulatory Ireland's Biopharma Sector: 21,000 Jobs Risk Skills Shortage

Ireland's biopharmaceutical industry is on the verge of substantial expansion, with an expected increase of 21,000 jobs by 2027. The Expert Group on Future Skills Needs (EGFSN) has highlighted the essential role of the biopharma sector in bolstering the national economy. Despite the optimistic

April 29, 2024
UD SABRE Center Boosts Biopharma with $45M Funding
Management & Regulatory UD SABRE Center Boosts Biopharma with $45M Funding

The University of Delaware is making major strides in the biopharma sector by launching the new SABRE Center. Backed by $45 million in federal funding, including $10 million from the American Rescue Plan, this 90,000-square-foot hub is set to propel the university into a leader in biopharmaceutical

April 26, 2024
Novartis Cuts Jobs Amid Global Restructure Efforts
Management & Regulatory Novartis Cuts Jobs Amid Global Restructure Efforts

Streamlining for Efficiency Reducing Workforce in Switzerland and the US In an ongoing effort to refine its operations, Novartis has announced a significant reduction in its workforce that will see between 400 and 440 jobs eliminated in Switzerland, specifically targeting operational and

April 3, 2024
Loading

Subscribe to our weekly news digest!

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for subscribing.
We'll be sending you our best soon.
Something went wrong, please try again later